Nanox reports $4.2 million Q2 revenue

• Nanox reported second quarter 2026 revenue of $4.2 million, up 37% year over year.
• The company posted a GAAP net loss of $55.5 million, including a $40.7 million non-cash impairment charge on AI-related intangible assets.
• Nanox expanded imaging distribution, increased health IT projects, and began a Korea restructuring expected to save about $2 million annually from 2027.

Nanox (NASDAQ:NNOX) reported second quarter 2026 revenue of $4.2 million, increasing 37% year over year as teleradiology and AI software sales contributed to results.

Revenue included $3 million from teleradiology, $1 million from AI and software solutions, and $0.2 million from imaging systems and original equipment manufacturer services.

The company reported a GAAP gross loss margin of 1,051%, while non-GAAP gross loss margin improved to 13% from 21% a year earlier, and adjusted EBITDA loss was $11.3 million.

Nanox reported a GAAP net loss of $55.5 million, including a $40.7 million non-cash impairment charge related to AI intangible assets, while cash and cash equivalents totaled $31.4 million at June 30, 2026.

Nanox develops medical imaging technologies and healthcare software solutions focused on expanding access to diagnostic services.